Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma.
- Resource Type
- Article
- Source
- JADPRO: Journal of the Advanced Practitioner in Oncology; Jan/Feb2022, Vol. 13 Issue 1, p77-85, 9p
- Subject
- Language
- ISSN
- 21500878